Hypoglycemia Flashcards

1
Q

blood glucose in hypoglycemia

A

less than 55 or even 40 mg/dL (2.2mM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

blood glucose fall abruptly and epinephrine stimulated

anxiety, palpitation, tremor, sweating

A

adrenergic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

characteristics of neuroglycopenia symptoms

A

gradual decline in blood glucose but epinephrine response not triggered

(headache, confusion, slurred speech, coma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

type of hypoglycemia symptoms that can lead to death

A

neuroglycopenia symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

transient hypoglycemia can lead to ________ while prolonged hypoglycemia can lead to _________.

A

cerebral dysfunction; coma even death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

patient is injected with _____ or _____ to activate liver’s release of glucose into blood

A

glucagon; epinepherine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Glucagon activates what processes?

A

glycogenolysis and gluconeogensis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cortisol activates ______ while epinephrine activates ____/

A

gluconeogenesis; glycogenolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

systems activated to normalize blood glucose levels

A

pituitary gland and ACTH; autonomic nervous system; alpha cells of pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what happens to type I diabetic patients that are injected with insulin

A

GLUT 4 activity picks up and muscle and adipose tissue take up glucose then eventually blood glucose level will drop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

used to treat type I diabetic patients when their blood glucose levels drops and needs to be normalized

A

glucagon and saline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

difference between treating type I diabetic patient with glucagon and saline

A

glucagon will increase blood glucose tremendously with glycogenolysis and gluconeogenesis before normalizing blood glucose while saline will gradually normalize blood glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

common type of hypoglycemia with mild adrenergic symptoms

A

post prandial hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

tumor of the pancreatic islet cells

A

insulinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

difference between post prandial and insulin induced hypoglycemia

A

post prandial - exaggerated insulin release by body following meal

insulin-induced - injected insulin of diabetic patient or persons with insulinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how to prevent post prandial hypoglycemia

A

frequent small meals (though plasma glucose levels returns to normal without eating if otherwise)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

treatment of insulin induced hypoglycemia

A

mild - carbs like OJ

severe - glucagon

18
Q

how do you tell if increased insulin is due to endogenous insulin production

A

insulin made in body has C peptide and proinsulin so they will be increased with increased insulin

injected/ exogenous insulin will have low C peptide and proinsulin with increased insulin

19
Q

most severe fasting hypoglycemia

A

Von Gierke - deficiency in glucose 6 phosphatase

20
Q

characteristic of patients with Von Gierke

A

hypoglycemia, hepatomegaly, enlarged kidney, lactic acidosis, gout

21
Q

deficiency in liver phosphorylase

A

Hers — hypoglycemia but mild

22
Q

deficient in Cori disease AKA limit dextrinosis

A

debranching enzyme in both liver and muscle

23
Q

what pathways do glucose 6 phosphatase work on

A

gluconeogenesis and glycogenolysis

24
Q

deficient in hereditary fructose intolerance

A

aldolase B

25
Q

what pathway needs aldolase B other than fructose metabolism

A

gluconeogenesis

26
Q

treatment of hereditary fructose intolerance

A

sucrose, fructose, and sorbitol removed from diet

dietary sorbitol used in liver to form fructose from sorbitol DH

27
Q

deficient in classical galactosemia

A

GALT - galactose 1-P uridyl transferase

28
Q

galactitol can lead to –>

A

liver damage, cataracts, severe mental retardation

29
Q

treatment of galactosemia

A

lactose and galactose removed from diet

30
Q

what happens with fructose 1-P when it accumulates in liver

A

reduces amount of inorganic phosphate which is needed for ATP synthesis and glycogen phosphorylase

31
Q

where does galactitol accumulate

A

liver, brain, nerve, lens, kidney

32
Q

seen in blood and urine in MCAD deficiency

A

dicarboxylic acids and fatty acyl carnitines (medium ones to be specific)

33
Q

damage in what organs can lead to carnitine deficiency

A

liver and kidney

34
Q

CPT-I deficiency can manifest as

A

hypoglycemia, hypoketosis, and if severe –> death

35
Q

characteristics of patients with high ethanol levels

A

high NADH/NAD+ levels, HYPOglycemia, HYPERketosis, lactic acidosis, ketoacidosis

36
Q

factitious hypoglycemia can be seen in patients who…

A

inject insulin but are non-diabetic or ingest sulfonyurea but are non-diabetic

37
Q

non-diabetic patients that inject insulin have high level of _____ but low levels of _______ and ______ with ______absent

A

insulin; C peptide; proinsulin; sulfonylurea

38
Q

nondiabetic patients that ingest sulfonylurea have high level of ______, _______, ______ and ________

A

insulin; C peptide; proinsulin; sulfonylurea

39
Q

sulfonylurea stimulates what from pancreas

A

endogenous insulin secretion

40
Q

severe form of factitious disorder (mental/personality disorder)

A

Munchhausen syndrome

41
Q

Patient with diabetes mellitus was on intensive therapy. He missed his treatment in the morning and took a double dose in the afternoon. He collapsed and was brought to the ER. His serum levels showed ______ insulin, _____ C peptide, _______ glucose

A

high insulin; low C peptide; low glucose